The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
This post first appeared in The New York Times – Business. Read the original article.Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles
The New York Times – Business:
Written by
in
